Home/Filings/4/0001493152-21-026985
4//SEC Filing

Corzo Kathryn Penkus 4

Accession 0001493152-21-026985

CIK 0001582554other

Filed

Nov 1, 8:00 PM ET

Accepted

Nov 2, 4:13 PM ET

Size

5.7 KB

Accession

0001493152-21-026985

Insider Transaction Report

Form 4
Period: 2021-11-01
Transactions
  • Award

    Stock option (right to buy)

    2021-11-01+181,763181,763 total
    Exercise: $1.12Exp: 2031-11-01Common Stock (181,763 underlying)
Footnotes (1)
  • [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 36 months commencing on November 30, 2021. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

Documents

1 file

Issuer

Matinas BioPharma Holdings, Inc.

CIK 0001582554

Entity typeother

Related Parties

1
  • filerCIK 0001884123

Filing Metadata

Form type
4
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 4:13 PM ET
Size
5.7 KB